Clinical Trials Directory

Trials / Unknown

UnknownNCT06231797

AI-ECG Screening for Left Ventricular Systolic Dysfunction

AI-ECG Screening for Left Ventricular Systolic Dysfunction: A Prospective, Observational, Multicenter Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,530 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The purpose of the current study is to verify the effectiveness of the artificial intelligence algorithm applied to the electrocardiogram as a potential screening tool for left ventricular systolic dysfunction.

Detailed description

The current investigators have developed an artificial intelligence (AI) algorithm based on 12-lead electrocardiogram (ECG) detecting left ventricular systolic dysfunction, through 364,845 ECGs from 148,547 patients. Then, when the model was tested retrospectively on 59,805 ECGs of 24,376 patients, the model performance expressed as an area under the receiver operating characteristic curve was 0.889 (95% CI 0.887-0.891). The investigators are planning to prospectively validate the model's effectiveness as a potential screening tool for left ventricular systolic dysfunction.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAI algorithm conducted on 12-lead ECG and transthoracic echocardiography12-lead ECG is performed for each patient. For 12-lead ECG, AITIALVSD (AI algorithm) analysis will be performed through a separate server.

Timeline

Start date
2024-02-01
Primary completion
2024-07-10
Completion
2025-07-10
First posted
2024-01-30
Last updated
2024-02-05

Source: ClinicalTrials.gov record NCT06231797. Inclusion in this directory is not an endorsement.